Daten zu öffentlichen Aufträgen und Fördermitteln in Europa aus amtlichen Registern · Datenstand: 17. November 2026, tägliche Aktualisierung.

Förderprogramm · Vereinigte Staaten

Cancer Detection and Diagnosis Research

Cancer Detection and Diagnosis Research (Vereinigte Staaten): Aufrufe und Förderungen des Programms. 52 Aufrufe auf der Seite, davon 10 offen; Aufrufe starten meist im November. Datenstand: 17. November 2026, tägliche Aktualisierung.

Fördergeber: National Institutes of Health (Department of Health and Human Services)

Förderungen der letzten 24 Monate
0
Empfänger
0
Offene Aufrufe
10
Aufrufe auf der Seite
52

Aufrufe starten meist im November

Über das Programm

Objectives: To improve screening and early detection strategies and to develop accurate diagnostic techniques and methods for predicting the course of disease in cancer patients. Screening and Early Detection research includes development of strategies to decrease cancer mortality by finding tumors…

Mehr in der Quelle

Offene Aufrufe

FörderaufrufStatusFrist
Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional) (Runde 11.2024 – 01.2027)Offen7. Januar 2027
Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)Offen11. Januar 2027
Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)Offen11. Februar 2027
Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed) (Runde 11.2024 – 01.2028)Offen7. Januar 2028
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional) (Runde 12.2024 – 01.2028)Offen7. Januar 2028
Forecast to Publish a Notice of Funding Opportunity for SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional)Geplant—
Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)Geplant—
Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)Geplant—
Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE, RP1 Clinical Trial Not Allowed)Geplant—
Radiation Oncology-Biology Integration Network (ROBIN) Centers (U54 Clinical Trial Required)Geplant—

Frühere Aufrufe

FörderaufrufStatusFrist
Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) (Runde 06.2026 – 11.2026)Abgelaufen10. November 2026
Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) (Runde 06.2026 – 11.2026)Abgelaufen10. November 2026
Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed) (Runde 10.2024 – 10.2026)Abgelaufen14. Oktober 2026
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed) (Runde 10.2024 – 10.2026)Abgelaufen14. Oktober 2026
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed) (Runde 10.2024 – 10.2026)Abgelaufen14. Oktober 2026
Innovative Research in Cancer Nanotechnology (IRCN; R01 Clinical Trial Not Allowed) (Runde 11.2024 – 05.2026)Abgelaufen4. Mai 2026
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional) (Runde 12.2024 – 12.2025)Abgelaufen9. Dezember 2025
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) (Runde 12.2024 – 12.2025)Abgelaufen9. Dezember 2025
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional) (Runde 12.2024 – 12.2025)Abgelaufen9. Dezember 2025
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) (Runde 12.2024 – 12.2025)Abgelaufen9. Dezember 2025
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) (Runde 12.2024 – 12.2025)Abgelaufen9. Dezember 2025
Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional) (Runde 12.2024 – 12.2025)Abgelaufen9. Dezember 2025
Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) (Runde 12.2024 – 12.2025)Abgelaufen9. Dezember 2025
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed) (Runde 10.2023 – 10.2025)Abgelaufen15. Oktober 2025
Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R21 Clinical Trial Not Allowed) (Runde 11.2024 – 05.2025)Abgelaufen7. Mai 2025
Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R01 Clinical Trial Not Allowed) (Runde 11.2024 – 05.2025)Abgelaufen7. Mai 2025
Limited Competition: NCI National Clinical Trials Network - Network Group Operations Centers (U10 Clinical Trial Required)Abgelaufen24. Februar 2025
NCI National Clinical Trials Network - Network Lead Academic Participating Sites (UG1 Clinical Trial Not Allowed)Abgelaufen24. Februar 2025
Limited Competition: NCI National Clinical Trials Network - Network Group Statistics and Data Management Centers (U10 Clinical Trial Required)Abgelaufen24. Februar 2025
NCI National Clinical Trials Network - Network Group Integrated Translational Science Centers (UG1 Clinical Trial Not Allowed)Abgelaufen24. Februar 2025

Förderkalender

Förderungen für Projekte mit Beginn zwischen 17. November 2024 und 17. November 2026; Beträge in Euro zum Eurostat-Kurs des jeweiligen Jahres.

Fragen und Antworten

Cancer Detection and Diagnosis Research: Wann starten die Förderaufrufe?
Derzeit offen (10): Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems… (7. Januar 2027), Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required) (11. Januar 2027), Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Bi… (11. Februar 2027), …. Aufrufe starten meist im November.